Clinical Trial Update: Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial of gemcitabine for advanced, unresectable salivary gland cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Salivary Gland Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED